paroxetine

FDA Drug Profile — BRISDELLE, PAROXETINE, Paroxetine

Drug Details

Generic Name
paroxetine
Brand Names
BRISDELLE, PAROXETINE, Paroxetine
Application Number
NDA204516
Sponsor
Legacy Pharma USA Inc.
NDC Codes
5
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
PAROXETINE MESYLATE

Indications and Usage

1 INDICATIONS AND USAGE Paroxetine extended-release tablets USP are indicated in adults for the treatment of: Major depressive disorder (MDD) Panic disorder (PD) Social anxiety disorder (SAD) Premenstrual dysphoric disorder (PMDD) Paroxetine extended-release tablet USP is a selective serotonin reuptake inhibitor (SSRI) indicated in adults for the treatment of ( 1 ): Major Depressive Disorder (MDD) Panic Disorder (PD) Social Anxiety Disorder (SAD) Premenstrual Dysphoric Disorder (PMDD)